Dogwood Therapeutics, Inc. Foreign Pre-Tax Income
Dogwood Therapeutics, Inc. (DWTX) reported Foreign Pre-Tax Income of -$9.23 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign · last filed 2026-08-14
- Dogwood Therapeutics, Inc. income (loss) from continuing operations before income taxes, foreign for the quarter ending 2026-06-30 was -$9.23M.
- Dogwood Therapeutics, Inc. income (loss) from continuing operations before income taxes, foreign for the quarter ending 2026-03-31 was -$107.75K.
- Dogwood Therapeutics, Inc. income (loss) from continuing operations before income taxes, foreign for the quarter ending 2025-09-30 was -$417.78K.
- Dogwood Therapeutics, Inc. income (loss) from continuing operations before income taxes, foreign for the quarter ending 2025-06-30 was -$758.55K.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Foreign 3 month | Income (Loss) from Continuing Operations before Income Taxes, Foreign 6 month | Income (Loss) from Continuing Operations before Income Taxes, Foreign 9 month |
|---|---|---|---|
| 2026-06-30 | -$9.23M 10-Q · filed 2026-08-14 | -$9.34M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$107.75K 10-Q · filed 2026-05-15 | ||
| 2025-09-30 | -$417.78K 10-Q · filed 2025-11-07 | -$1.18M derived: sum of 2 quarters · filed 2026-08-14 | -$1.58M 10-Q · filed 2025-11-07 |
| 2025-06-30 | -$758.55K 10-Q · filed 2026-08-14 | -$1.17M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | -$407.42K 10-Q · filed 2026-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |